We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IRS:NYSEIRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of Analysis

Data as of 2026-06-18 - not real-time

$16.43

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

IRSA (IRS) is trading at $16.43, comfortably above its 20‑day ($15.40), 50‑day ($15.04) and 200‑day ($14.86) simple moving averages, indicating a strong bullish trend. The 14‑day RSI sits at 58.7 and the MACD line is positive and above its signal, while volume is on the rise, reinforcing short‑term momentum. However, the stock exhibits very high 30‑day volatility (~54%) and a computed beta of 1.54, signaling pronounced price swings and heightened market sensitivity, a point underscored by the “Extreme Greed” reading on the Fear & Greed Index (88.5).
Fundamentally, IRS appears deeply undervalued with a trailing P/E of 4.99 versus an industry average of 32.39 and a P/B of 0.94, while delivering a staggering 14.27% dividend yield on a 43.7% payout ratio. Revenue is growing at 29% YoY, margins are robust (gross 64.6%, operating 44.4%, profit 72.5%) and cash generation is strong (free cash flow $172 B). The balance sheet is leveraged (debt‑to‑equity 44.6) but ample operating cash flow suggests debt service is manageable. Overall, the stock combines attractive valuation and cash yield with significant macro‑ and country‑specific risks.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical setup (price above SMAs, positive MACD, rising volume)
  • High dividend yield providing immediate income
  • Support level well below current price offering downside cushion

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Significant valuation discount vs peers
  • Elevated debt load and Argentine macro‑economic uncertainty
  • Sustained revenue growth and strong cash flow supporting operations

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Persistent undervaluation (low P/E, P/B) creating upside potential
  • Robust dividend yield with reasonable payout ratio for compounding returns
  • Strong operating margins and cash generation underpinning long‑term stability

Key Metrics & Analysis

Financial Health

Revenue Growth29.30%
Profit Margin72.51%
P/E Ratio5.0
ROE22.48%
ROA4.07%
Debt/Equity44.65
P/B Ratio0.9
Op. Cash Flow$216.7B
Free Cash Flow$172.3B
Industry P/E32.4

Technical Analysis

TrendBullish
RSI58.7
Support$13.40
Resistance$17.45
MA 20$15.40
MA 50$15.04
MA 200$14.86
MACDBullish
VolumeIncreasing
Fear & Greed Index88.5

Valuation

Fair Value$63,926.64
Target Price$21.33
Upside/Downside29.84%
GradeUndervalued
TypeBlend
Dividend Yield14.27%

Risk Assessment

Beta1.54
Volatility53.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.